41 related articles for article (PubMed ID: 24045544)
1. Interobserver concordance in implementing the 2010 ASCO/CAP recommendations for reporting ER in breast carcinomas: a demonstration of the difficulties of consistently reporting low levels of ER expression by manual quantification.
Reisenbichler ES; Lester SC; Richardson AL; Dillon DA; Ly A; Brock JE
Am J Clin Pathol; 2013 Oct; 140(4):487-94. PubMed ID: 24045544
[TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
Hammond ME; Hayes DF; Dowsett M; Allred DC; Hagerty KL; Badve S; Fitzgibbons PL; Francis G; Goldstein NS; Hayes M; Hicks DG; Lester S; Love R; Mangu PB; McShane L; Miller K; Osborne CK; Paik S; Perlmutter J; Rhodes A; Sasano H; Schwartz JN; Sweep FC; Taube S; Torlakovic EE; Valenstein P; Viale G; Visscher D; Wheeler T; Williams RB; Wittliff JL; Wolff AC
Arch Pathol Lab Med; 2010 Jun; 134(6):907-22. PubMed ID: 20524868
[TBL] [Abstract][Full Text] [Related]
3. The Co-Expression of Estrogen Receptors ERα, ERβ, and GPER in Endometrial Cancer.
Hojnik M; Sinreih M; Anko M; Hevir-Kene N; Knific T; Pirš B; Grazio SF; Rižner TL
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769338
[TBL] [Abstract][Full Text] [Related]
4. Clinical implication of low estrogen receptor (ER-low) expression in breast cancer.
Reinert T; Cascelli F; de Resende CAA; Gonçalves AC; Godo VSP; Barrios CH
Front Endocrinol (Lausanne); 2022; 13():1015388. PubMed ID: 36506043
[TBL] [Abstract][Full Text] [Related]
5. Integrating and validating automated digital imaging analysis of estrogen receptor immunohistochemistry in a fully digital workflow for clinical use.
Shafi S; Kellough DA; Lujan G; Satturwar S; Parwani AV; Li Z
J Pathol Inform; 2022; 13():100122. PubMed ID: 36268080
[TBL] [Abstract][Full Text] [Related]
6. Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer.
Chen L; Chen Y; Xie Z; Luo J; Wang Y; Zhou J; Huang L; Li H; Wang L; Liu P; Shu M; Zhang W; Ke Z
Breast Cancer Res Treat; 2022 Aug; 194(3):517-529. PubMed ID: 35789315
[TBL] [Abstract][Full Text] [Related]
7. Assessment of estrogen receptor low positive status in breast cancer: Implications for pathologists and oncologists.
Fusco N; Ragazzi M; Sajjadi E; Venetis K; Piciotti R; Morganti S; Santandrea G; Fanelli GN; Despini L; Invernizzi M; Cerbelli B; Scatena C; Criscitiello C
Histol Histopathol; 2021 Dec; 36(12):1235-1245. PubMed ID: 34585734
[TBL] [Abstract][Full Text] [Related]
8. Automated immunohistochemical assessment ability to evaluate estrogen and progesterone receptor status compared with quantitative reverse transcription-polymerase chain reaction in breast carcinoma patients.
Jeon T; Kim A; Kim C
J Pathol Transl Med; 2021 Jan; 55(1):33-42. PubMed ID: 33260290
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Breast Cancer: A Propensity Score-Matching Study.
Hua X; Long ZQ; Zhang YL; Wen W; Guo L; Xia W; Zhang WW; Lin HX
Front Oncol; 2020; 10():580. PubMed ID: 32373539
[No Abstract] [Full Text] [Related]
10. Regional nodal irradiation in pT1-2N1 breast cancer patients treated with breast-conserving surgery and whole breast irradiation.
Park SH; Kim JC
Radiat Oncol J; 2020 Mar; 38(1):44-51. PubMed ID: 32229808
[TBL] [Abstract][Full Text] [Related]
11. Association between low estrogen receptor positive breast cancer and staining performance.
Caruana D; Wei W; Martinez-Morilla S; Rimm DL; Reisenbichler ES
NPJ Breast Cancer; 2020; 6():5. PubMed ID: 32047851
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a novel nomogram for predicting distant metastasis-free survival among breast cancer patients.
Wang Y; Yang Y; Chen Z; Zhu T; Wu J; Su F; Deng H
Ann Transl Med; 2019 Oct; 7(20):537. PubMed ID: 31807519
[TBL] [Abstract][Full Text] [Related]
13. Higher ER load is not associated with better outcome in stage 1-3 breast cancer: a descriptive overview of quantitative HR analysis in operable breast cancer.
Noordhoek I; de Groot AF; Cohen D; Liefers GJ; Portielje JEA; Kroep JR
Breast Cancer Res Treat; 2019 Jul; 176(1):27-36. PubMed ID: 30997625
[TBL] [Abstract][Full Text] [Related]
14. Local and regional recurrence following mastectomy in breast cancer patients with 1-3 positive nodes: implications for postmastectomy radiotherapy volume.
Park SH; Lee J; Lee JE; Kang MK; Kim MY; Park HY; Jung JH; Chae YS; Lee SJ; Kim JC
Radiat Oncol J; 2018 Dec; 36(4):285-294. PubMed ID: 30630267
[TBL] [Abstract][Full Text] [Related]
15. Intra-tumor molecular heterogeneity in breast cancer: definitions of measures and association with distant recurrence-free survival.
Saha A; Harowicz MR; Cain EH; Hall AH; Hwang ES; Marks JR; Marcom PK; Mazurowski MA
Breast Cancer Res Treat; 2018 Nov; 172(1):123-132. PubMed ID: 29992418
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the HER2 and Hormone Receptor Status in Metastatic Breast Cancer Using Cell Blocks: A Multi-Institutional Study.
Nishimura R; Murata Y; Mori K; Yamashiro K; Kuraoka K; Ichihara S; Taguchi K; Suzuki H; Ito M; Yamashita N
Acta Cytol; 2018; 62(4):288-294. PubMed ID: 29763896
[TBL] [Abstract][Full Text] [Related]
17. The Core Needle and Surgical Biopsy Concordance to Detect Estrogen, Progesterone, and Her-2 Receptors in Breast Cancer: A Comparative Study.
Ensani F; Omranipour R; Jahanzad I; Jafari A; Nafarzadeh S; Aminishakib P
Iran J Pathol; 2017; 12(3):202-208. PubMed ID: 29531544
[TBL] [Abstract][Full Text] [Related]
18. Improving accuracy of breast cancer biomarker testing in India.
Shet T
Indian J Med Res; 2017 Oct; 146(4):449-458. PubMed ID: 29434058
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer subtype discrimination using standardized 4-IHC and digital image analysis.
Gándara-Cortes M; Vázquez-Boquete Á; Fernández-Rodríguez B; Viaño P; Ínsua D; Seoane-Seoane A; Gude F; Gallego R; Fraga M; Antúnez JR; Curiel T; Pérez-López E; García-Caballero T
Virchows Arch; 2018 Feb; 472(2):195-203. PubMed ID: 28825136
[TBL] [Abstract][Full Text] [Related]
20. Whole tumor section quantitative image analysis maximizes between-pathologists' reproducibility for clinical immunohistochemistry-based biomarkers.
Barnes M; Srinivas C; Bai I; Frederick J; Liu W; Sarkar A; Wang X; Nie Y; Portier B; Kapadia M; Sertel O; Little E; Sabata B; Ranger-Moore J
Lab Invest; 2017 Dec; 97(12):1508-1515. PubMed ID: 28805805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
